Cordycepin in cancer therapy: A bibliometric analysis and review of mechanisms

Zhiwei Ouyang, Jiangxi Key Laboratory of Natural Microbial Medicine Research, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China
Yufei Zhang, Jiangxi Key Laboratory of Natural Microbial Medicine Research, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China.
Jianghan Ning, Jiangxi Key Laboratory of Natural Microbial Medicine Research, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China
Yayi Tu, Jiangxi Key Laboratory of Natural Microbial Medicine Research, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, ChinaFollow
Bin He, Jiangxi Key Laboratory of Natural Microbial Medicine Research, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China.Follow

Keywords

Adenosin deaminase (ADA), Bibliometrics, Cordycepin, Cancer, Cell cycle

Abstract

Cordycepin (3’-deoxyadenosine), a major bioactive component derived from fungi of the genus Cordyceps, has garnered significant attention in recent years for its potent antitumor properties. Drawing on literature indexed in the Web of Science Core Collection from 2004 to 2025, this study employs bibliometric tools―specifically CiteSpace and VOSviewer―to systematically examine developmental trends, research hotspots, and emerging frontiers in the field of cordycepin-related cancer research. The analysis maps a shift in focus from early-stage pharmacological validation to more advanced investigations into molecular mechanisms, with particular emphasis on cell cycle regulation. Keyword burst analysis highlights bursts in terms such as “apoptosis,” “cell cycle,” “gene,” and “expression,” underscoring that modulating the cell cycle to induce cancer cell apoptosis has become a central research theme. Building on these findings, the review further delineates the specific molecular mechanisms by which cordycepin regulates cell cycle progression in various tumor types―primarily through downregulation of Cyclin/CDK complexes, upregulation of p21 and p27, and activation of DNA damage response pathways. Additionally, growing evidence indicates that cordycepin's influence on gene expression and epigenetic modulation is emerging as a critical area of focus. Taken together, cordycepin demonstrates multitargeted potential in inhibiting tumor growth, positioning it as a promising candidate for natural anticancer drug development. Future research should prioritize pharmacokinetic characterization, investigation of combinatorial therapeutic strategies, and pathways toward clinical translation. Intracellular exposure appears to be shaped by two complementary axes: interference with 3'end polyadenylation and ENT1/ENT2-mediated uptake with ADA-catalyzed deamination.

Abstract Image

Recommended Citation

Ouyang, Zhiwei; Zhang, Yufei; Ning, Jianghan; Tu, Yayi; and He, Bin (2025) "Cordycepin in cancer therapy: A bibliometric analysis and review of mechanisms," Journal of Food and Drug Analysis: Vol. 33 : Iss. 4 , Article 2.
Available at: https://doi.org/10.38212/2224-6614.3566